Max Healthcare (MAXHEALTH)

FairStock Score: 54/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Strong profit growth of 17.2% showing healthy business expansion
• Market leadership position in premium healthcare services sector
• Healthy ROCE of 14.9% indicating efficient capital utilization

Concerns

• Extremely high P/E ratio of 72.8 compared to historical norms
• Very low dividend yield of 0.1% offers minimal immediate returns
• DhanIQ score of 3/10 suggests overvaluation concerns

AI Analysis

Max Healthcare is a Stalwart company — operating in India's growing healthcare sector with a market cap of Rs 1.1 lakh crore. The data indicates this hospital chain is trading at Rs 1,100 per share with a P/E ratio of 72.8, which appears significantly elevated compared to historical market norms where quality companies typically trade between 15-25 times earnings. Analysis suggests the company is delivering solid fundamentals with profit growth of 17.2% and sales growth of 10.7%, indicating healthy business expansion. The ROCE of 14.9% shows management is generating reasonable returns on capital employed. However, the dividend yield of just 0.1% suggests the company is retaining most profits for growth rather than rewarding shareholders immediately. The DhanIQ score of 3 out of 10 classified as WEAK raises concerns about current valuation levels. Investors may consider that while Max Healthcare demonstrates strong market leadership in premium healthcare services and consistent earnings growth, the high P/E ratio suggests the market has already priced in significant future growth expectations. The acceleration potential remains promising given India's expanding healthcare needs, but the valuation premium requires careful monitoring.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer